The Clinical and Economic Impact of Biologic Agents in Asthma Management: a Systematic Review. [PDF]
Procacci C +5 more
europepmc +1 more source
Real-World Effectiveness of Biologic Therapies for Severe Asthma in a Diverse Middle Eastern Cohort: Evaluation of Longitudinal Symptom Improvement. [PDF]
Kareem MA +4 more
europepmc +1 more source
Eosinophilic Granulomatosis with Polyangiitis that Manifested after Administration of Benralizumab in a Patient with Refractory Recurrent Bronchial Asthma. [PDF]
Yamamoto U +15 more
europepmc +1 more source
Benralizumab: Bringing winds of change to eosinophil-associated diseases. [PDF]
Korn S +5 more
europepmc +1 more source
From Anti-Neutrophil Cytoplasmic Antibody-Negative to Positive: Eosinophilic Granulomatosis with Polyangiitis Under Benralizumab After Steroid Cessation. [PDF]
Işık Ş +4 more
europepmc +1 more source
CRSwNP in the biologics era: evaluating patient-reported quality of life outcomes. [PDF]
Kang T +6 more
europepmc +1 more source
Comparative effectiveness of biologics in lung function improvement among patients with severe asthma: a real-world study. [PDF]
Bourdin A +12 more
europepmc +1 more source
Clinical Remission in Severe T2-High Asthma in Real Life After Anti-IgE, Anti-IL-5 and Anti-IL5R: A Potential Role for CRP as a Biomarker. [PDF]
Vervier J +12 more
europepmc +1 more source
Functional respiratory imaging reveals early structural and functional airway responses to benralizumab in severe eosinophilic asthma. [PDF]
Conemans L +5 more
europepmc +1 more source
Biologics in Chronic Obstructive Pulmonary Disease: Current Status and Future Prospects. [PDF]
Choi JY.
europepmc +1 more source

